ALOE VERA ETHANOL EXTRACT AS A THERAPY FOR ALVEOLAR MANDIBLE REGENERATION IN LIPOPOLYSACCHARIDE-EXPOSED RATS by Rakhman, Latifah Fitriani et al.
ISSN - 0975-7058 
Vol 10, Special Issue 1, 2018
ALOE VERA ETHANOL EXTRACT AS A THERAPY FOR ALVEOLAR MANDIBLE REGENERATION 
IN LIPOPOLYSACCHARIDE-EXPOSED RATS
LATIFAH FITRIANI RAHMAN1, OCTAVIANA WIDYA PANGESTIKA1, DELVI FITRIANI1*, 
RUDHANTON RUDHANTON2, NUR PERMATASARI3
1Department of Academic Faculty of Dentistry, University of Brawijaya, Malang 65145, Indonesia. 2Department of Periodontia, Faculty of 
Dentistry, University of Brawijaya, Malang 65145, Indonesia. 3Department of Oral Biology, Faculty of Dentistry, University of Brawijaya, 
Malang 65145, Indonesia. Email: delfifitriani@yahoo.com
Received: 29 June 2018, Revised and Accepted: 08 August 2018 and 15 November 2018
ABSTRACT
Objective: The study examined the effects of Aloe vera ethanol extract on alveolar mandible regeneration in rats (Rattus norvegicus).
Methods: Rats were divided into five groups as follows: Negative control group received no treatment, positive control group received Escherichia 
coli lipopolysaccharide (LPS) alone for 5 days, and Groups P1, P2, and P3 received LPS for 5 days followed by 40, 80, and 160 mg/kg BW A. vera 
ethanol extract, respectively, orally on days 6–12. Alveolar bone tissues were taken and histologically processed through hematoxylin-eosin staining. 
Osteoblast and osteoclast numbers in alveolar tissue were also examined.
Results: One-way ANOVA revealed strong relationships between the A. vera ethanol extract dosage and the numbers of osteoblasts (r=0.921, p<0.05) 
and osteoclasts (r=−0.631, p<0.05) in rats.
Conclusion: A. vera ethanol extract appears capable of stimulating alveolar bone regeneration following LPS exposure.
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INTRODUCTION
Periodontal disease is common and widespread and can affect children, 
adults, and the elderly. The 2003 World Oral Health Report identified 
periodontal disease as the fourth most expensive disease to treat. The 
Scheffler survey revealed that 75% of the American population has 
periodontal disease. The prevalence of periodontal disease in all age 
groups in Indonesia has reached 96.58% [1], whereas data from the 
Department of Health of Malang indicated that periodontal disease is 
the seventh most common disease in the state [2].
Periodontitis, a cause of tooth loss in adults, is a chronic infection of 
tooth-supporting tissues including the gingiva, periodontal ligament, 
bone, and cementum by bacteria. Substances produced by bacteria 
cause tissue inflammation and progressive alveolar bone damage, 
which are the main characteristics of periodontitis [3]. The major 
microbes that cause periodontitis are Porphyromonas gingivalis, 
Prevotella intermedia, and Actinobacillus actinomycetemcomitans; 
however, other microbes including Gram-negative bacteria such as 
Escherichia coli, Fusobacterium nucleatum, and Actinomyces israelii can 
also trigger periodontitis [4].
Gram-negative bacterial species produce lipopolysaccharide (LPS), a 
structural component of the outer membrane that protects bacteria 
against host immune defenses [5]. LPS induces the production of 
local factors, namely pro-inflammatory cytokines such as interleukin-
1α (IL-1α), IL-1β, tumor necrosis factor-α (TNF-α), and eicosanoids, 
including prostaglandin E2 (PGE2). Prostaglandins and pro-
inflammatory cytokines promote destruction of periodontal tissue 
by stimulating osteoclast production and activity and decreasing the 
numbers and activity of osteoblasts [6]. Umezu et al. revealed that mice 
injected with E. coli LPS in the mucosal region of the maxillary first 
molar exhibit alveolar bone resorption caused by excessive osteoclast 
numbers and activity.
Alveolar bone regeneration is a suitable treatment goal for patients with 
periodontitis and severe bone destruction. Regenerative periodontal 
tissue healing occurs through the formation of new periodontal tissues, 
particularly the alveolar bone, functional periodontal ligament, and 
cementum. Increased osteoclastogenesis is one indicator of bone 
regeneration [7].
Several studies previously reported the efficacy of Aloe vera 
(Aloe chinensis) in healing bone defects. A. vera is considered to express 
biogenic stimulators and wound healing hormones because it promotes 
cell regeneration. A. vera contains acetylated mannose (acemannan), a 
large polysaccharide that promotes the formation of collagen type 1 
fibers and acts as an immunostimulator enhancing T-helper immune 
responses against intracellular pathogens such as viruses, bacteria, and 
parasites. Another study conducted by Jittapiromsak et al. postulated 
that acemannan can stimulate bone morphogenetic protein-2 (BMP2) 
expression in pulpal fibroblasts and periodontal tissues, thus resulting 
in bone regeneration. Furthermore, Kresnohadi combined A. vera 
and xenograft cancellous grafts, thus observing increases in BMP2 
expression and osteoblast counts as well as decreased receptor 
activator of nuclear factor kappa-Β ligand (RANKL) expression, which 
is an indicator of decreased osteoclast production [8].
Most current studies have found that molecular signals trigger the 
formation of complex tissues. Molecular biology studies identified BMP 
as a bone differentiation initiator. BMP regulates cartilage and bone 
differentiation as well as bone growth through progenitors that trigger 
osteoblast formation [9].
Thus, the effects of A. chinensis baker ethanol extract on LPS-
induced alveolar bone destruction were examined in male rats 
(Rattus norvegicus) based on osteoblast and osteoclast counts.
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METHODS
Research design
This in vivo study was randomized and controlled in nature.
Samples
The study samples included male rats maintained in the Pharmacology 
Laboratory of the Faculty of Medicine, Brawijaya University, Malang. The 
rats were 2 months old, healthy, active with normal behavior and weighed 
200–250 g. Rats used in previous studies, those with a lack of appetite, 
those in poor condition as well as dead rats were excluded from the study.
Variables
The study variables were as follows:
a. Independent variable: A. vera ethanol extract;
b. Dependent variable: Number of osteoclasts;
c. Control: Simple criteria, method for administering LPS, and method 
for administering A. vera extract.
Six repetitions were performed. The rats were divided into five groups: A 
negative control group that received no treatment, a positive control group 
that received LPS alone, and three experimental groups treated with LPS 
followed by 200, 400, or 800 mg/200 kg BW of A. vera ethanol extract.
Setting and time of the study
The study was conducted at the Pharmacology and Anatomical 
Pathology Laboratory of the Faculty of Medicine, Brawijaya University, 
between December 2014 and February 2015.
PROCEDURE
Ethical clearance
The study was ethically approved by the Medical Research Ethics 
Commission of the Faculty of Medicine, Brawijaya University.
Sample preparation
Male rats were weighed using an analytical scale. The rats were 
allowed to adapt to the environment for 1 week and maintained in 
40 cm × 30 cm × 30 cm3 cages. Each cage included no more than two 
animals.
Dosage conversion
a. LPS dosage=5 μg/0.05 ml of PBS,
b. A. vera.
The conversion factor between a 70 kg man and 200 g mouse was 0.018. 
The recommended A. vera dosage for humans is 10–15 g/day. Thus, the 
A. vera dose for rats was calculated as follows:
 =0.018×10 g
 =0.18 g/200 g BW
 =180 mg/200 g BW≈36 mg/kg BW.
The extract was prepared at three different dosages:
• 40 mg/kg BW for Group A
• 80 mg/kg BW for Group B
• 160 mg/kg BW for Group C.
Sample grouping
a. Group 1: Negative control group (K−) that was not administered LPS 
or A. vera ethanol extract;
b. Group 2: Positive control group (K+) administered LPS alone;
c. Group 3: (P1) Group administered LPS followed by 40 mg/kg BW 
A. vera ethanol extract;
d. Group 4: (P2) Group administered LPS followed by 80 mg/kg BW 
A. vera ethanol extract;
e. Group 5: (P3) Group administered LPS followed by 160 mg/kg BW 
A. vera ethanol extract.
Material preparation
Material used during the experiment included E. coli LPS (Sigma) to induce 
periodontitis and A. vera ethanol extract to stimulate alveolar bone repair.
LPS preparation
Totally, 10 mg of LPS was dissolved in 2 ml of PBS and stored in a sealed 
container at room temperature.
A. vera ethanol extract preparation
The A. vera ethanol extract was obtained through maceration. The 
process required approximately 200–400 g of A. vera powder as 
the main raw material, 200 ml of 96% ethanol for polysaccharide 
deposition, a deposition time of 10 h, and a precipitation temperature 
of 10°C. The preparations were then filtered into a porcelain bowl and 
allowed to stand uncovered at room temperature for 1 day. Following 
evaporation, the extract was stored in a container in a cool place and 
protected from sunlight [10].
EXPERIMENTS
Sedating the animals
Before treatment, the rats were sedated by administering an injection 
of ketamine (KTM 100; 40 mg/kg BW) into the right hind leg.
Applying the materials
LPS (5 μg/0.05 ml) was injected into the first incisive tooth gingival 
sulcus located on the mandibular right labia. PBS (0.02 ml) was injected 
using a 30-G insulin needle once daily for 5 days. The first incisor was 
selected because it is categorized as a front tooth and is, therefore, more 
visible than the other teeth.
Using a feeding tube, A. vera ethanol extract (1 ml) was administered for 
7 days starting on day 6.
Alveolar mandible surgery
The surgery was conducted after 7 days of treatment with A. vera.
The rats were sedated using KTM (80 mg/kg BW), and their alveolar 
mandible bone was horizontally cut. The dead animals were then cleaned, 
sterilized using 70% alcohol, and buried into a 100 cm × 30 cm × 50 cm3 
hole in the backyard of the Pharmacology Laboratory. Each hole contained 
24 dead rats. The mandibles were preserved using 10% formalin for 
24 h and 10% EDTA for 14 days to decalcify the tissue. The solution was 
changed every 24 h, and the bones were washed under running water.
Paraffin block preparation
Tissues were dehydrated using acetone for 24 h and cleared using xylol 
twice for 1 h each. Next, infiltration was done using soft paraffin at 
42°C–46°C twice for 1 h each followed by blocking with hard paraffin 
at 46°C–52°C for 1 h. Afterward, the tissue was cut vertically using a 
4–6-μm microtome rotary and then heated at 60°C. The tissue was then 
soaked in xylol twice for 5 min each followed by a series of different 
concentrations of alcohol (95%, 85%, 70%, 50%, and 30%) twice for 
3 min each.
For hematoxylin-eosin staining, tissues were incubated in Harris 
hematoxylin for 15 min followed by acid alcohol drops for 3–10 s and 
ammonium solution for 3–10 s. This was followed by counterstaining 
for 15–20 s and dehydrating using the ethanol series. Then, tissues were 
exposed to xylol for 5 min and mounted for observation using a digital 
microscope (five fields, ×400) to count the numbers of osteoblasts and 
osteoclasts with the assistance of an anatomical pathology lecturer and 
laboratory analyst.
Data analysis
Normality was assessed using the Shapiro–Wilk test because the 
number of samples exceeded 50. A two-tailed t-test was used 
to compare scores between two groups, with p<0.05 indicating 
statistically significant differences. Levene’s test was used to compare 
normality and variance homogeneity between the positive control 
and experimental groups. When the data were normally distributed 
(p>0.05) and variance homogeneity was accepted (p>0.05), one-way 
ANOVA was conducted for hypothesis testing. Post hoc testing was then 
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used to identify significant differences based on ANOVA. Finally, the 
correlation-regression test was performed to assess the relationship 
between the A. vera dosage and osteoblast and osteoclast counts.
RESULTS
Figs. 1 and 2 show that osteoblast numbers were the lowest in the 
negative control group, whereas osteoclast counts were the highest in 
this group. Meanwhile, osteoblast counts increased with an increasing 
dosage of the A. vera ethanol extract; however, the opposite was seen 
in the case of osteoclasts. Figs. 3 and 4 show histological comparison of 
osteoblasts and osteoclast counts.
The Shapiro–Wilk test demonstrated that the data for osteoblasts 
and osteoclasts were normally distributed (p<0.05). The Levene’s 
homogeneity test illustrated that the variance was homogenous in both 
osteoblast (p=0.336) and osteoclast data (p=0.700). Meanwhile, one-
way ANOVA revealed significant differences in osteoblast (p=0.000) and 
osteoclast counts (p=0.012) based on the A. vera ethanol extract dosage.
The results of post hoc testing using the least significant difference test 
revealed significant differences between the control and experimental 
groups as well as among the experimental groups regarding the 
numbers of osteoblasts and osteoclasts.
The Pearson correlation test was employed to assess the correlation 
between the A. vera extract dosage and the numbers of osteoblasts 
and osteoclasts. A strong and positive correlation (r=0.921, p=0.001) 
was found between the A. vera extract dosages and osteoblast count, 
whereas an inverse correlation was observed between the dosage and 
osteoclast count (r=−0.631, p=0.001).
DISCUSSION
The study results revealed significant differences in osteoblast and 
osteoclast numbers between rats exposed to LPS alone and those exposed 
to LPS followed by A. vera ethanol extract. LPS stimulates osteoclast 
production, thereby resulting in tissue resorption. LPS functions as an 
endotoxin by binding to CD14 receptors in macrophages and monocytes. 
This binding induces the production of arachidonic acid (AA), which 
stimulates the secretion of cytokines such as IL-1α, IL-1β, IL-6, TNF-α, and 
PGE2 [11]. Prostaglandins and pro-inflammatory cytokines, which play 
important roles in bone pathology, are associated with bone destruction 
caused by localized chronic inflammation by increasing osteoclast 
formation, differentiation, and activation directly as well as by inhibiting 
osteoblast function [12]. Previous studies conducted by Indahyani et al. 
also proved that exposure to E. coli LPS leads to periodontitis.
Fig. 1: Average number of osteoblasts in the groups.  
Description: K/P0: Lipopolysaccharide (LPS) treatment 
alone, P1: LPS treatment followed by 40 mg of Aloe chinensis 
baker ethanol extract, P2: LPS treatment followed by 80 mg of 
A.chinensis baker ethanol extract, P3: LPS treatment followed by 
160 mg of A. chinensis baker ethanol extract
Fig. 2: Average number of osteoclasts in the groups. 
Description: K/P0: Lipopolysaccharide (LPS) treatment 
alone. P1: LPS treatment followed by 40 mg of Aloe chinensis 
baker ethanol extract, P2 LPS treatment followed by 80 mg of 
A. chinensis baker ethanol extract, P3 LPS treatment followed by 
160 mg of A. chinensis baker ethanol extract
Fig. 4: Histological comparison of osteoclast counts. 
Description: (a) P1: Lipopolysaccharide (LPS) induction +40 mg 
of A. vera extract, (b) P2: LPS induction +80 mg of A. vera extract, 






Fig. 3: (a-d) Histological comparison of osteoblast counts
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The finding that the osteoblast numbers increase with increasing 
A. vera extract dosage corroborates with the hypothesis that acemannan 
can stimulate BMP2 expression and type 1 collagen fiber formation in 
periodontal tissue, thus facilitating bone regeneration by increasing 
osteoblast counts and decreasing osteoclast numbers in the alveolar 
bone. Acemannan is the largest polysaccharide capable of reducing 
inflammation through prostaglandin synthesis [13]. A. vera extract 
also inhibits AA-induced prostaglandin and thromboxane production 
through antagonism by eicosapentaenoic acid (EPA) [14,15]. 
In the body, EPA mostly interacts with AA metabolites. EPA is a 
polyunsaturated fatty acid that acts as a precursor for prostaglandin-3 
(which inhibits platelet aggregation), thromboxane-3, and 
leukotriene-5. This substitution may result in the decreased release 
of pro-inflammatory signals, thus leading to decreased cytokine 
production.
A decrease in inflammatory mediator levels may also decrease 
osteoclastogenesis. Osteoblasts and stromal cells produce 
osteoprotegerin (OPG), which competes with RANKL for binding 
to RANK, thus suppressing osteoclast formation. When the OPG 
concentration exceeds that of RANKL, OPG binds to RANK and inhibits 
binding by RANKL. A study conducted by Kresnohadi demonstrated 
that acemannan can increase BMP2 expression and thereby lead to 
increased osteoblast formation and decreased expression of IL-1β and 
RANKL, which are markets of osteoclastogenesis and alveolar bone 
resorption [16].
The finding of the correlations between the A. vera extract dosage 
and osteoblast and osteoclast counts corroborates with data 
reported by Manoglas, as cited by Lindawati that BMP-2 stimulates 
osteoblastogenesis with increasing A. vera dosage [17]. In addition, 
A. vera also contains Vitamin A, which has significant roles in cell 
differentiation and strengthening of collagen and Vitamin C bound 
stimulating type-1 collagen, accumulation of osteoblasts, and matrix 
mineralization in osteoblasts. Vitamin C also maintains bone mass 
by stimulating osteoblast formation to promote the development of 
new bone and suppressing bone resorption by inhibiting osteoblast 
formation [18-20].
Linear regression analysis demonstrated that the R2 was 0.398, thus 
illustrating that most effects of A. vera extract on osteoclasts were 
attributable to factors not analyzed in this study. These include the 
animal’s conditions and the extract storage time, and other chemicals 
present in A. vera.
The hypothesis that A. vera extract can stimulate alveolar bone regeneration 
was successfully proved, as indicated by the increased number of 
osteoblasts and decreased a number of osteoclasts in LPS-treated rats.
CONCLUSION
A. vera ethanol extract appeared to promote alveolar bone 
regeneration in LPS-treated male rats based on the findings of 
increased osteoblastogenesis and decreased osteoclastogenesis. The 
A. vera extract dosage positively correlated with osteoblast counts and 
negatively correlated with osteoclast counts.
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